CRISPR Therapeutics AG Contracts & Agreements

67 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Non-Qualified Stock Option Agreement for Company Employees under CRISPR Therapeutics AGs 2018 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Form of Indemnification Agreement
Indemnification Agreements
CRISPR Therapeutics AG
2024
Employment Agreement, dated May 28, 2024, by and between CRISPR Therapeutics, Inc. and Naimish Patel, M.D
Employment Agreements
CRISPR Therapeutics AG
2024
Description of Capital Shares
CRISPR Therapeutics AG
2024
Form of Investment Agreement
Investment Agreements
CRISPR Therapeutics AG
2024
Amendment No. 1 to the Amended and Restated Joint Development and Commercialization Agreement, dated December 12, 2023, by and between, on the one hand, Vertex Pharmaceuticals...
Development Agreements
CRISPR Therapeutics AG
2023
Lease Commencement Date Agreement, dated May 1, 2022, by and between CRISPR Therapeutics AG and 105 W First Street Owner, L.L.C
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
2022
Employment Agreement, dated May 23, 2022, by and between CRISPR Therapeutics AG and Phuong Khanh Morrow
Employment Agreements
CRISPR Therapeutics AG
2022
Letter Agreement dated January 6, 2022, by and between CRISPR Therapeutics, Inc. and 105 W First Street Owner, L.L.C
CRISPR Therapeutics AG
Biotechnology
2022
Letter Agreement dated December 16, 2021 by and between CRISPR Therapeutics, Inc. and Pfizer Inc
CRISPR Therapeutics AG
2022
Description of Capital Shares
CRISPR Therapeutics AG
2022
Employment Agreement, dated October 14, 2021, by and between CRISPR Therapeutics, Inc. and Brendan Smith
Employment Agreements
CRISPR Therapeutics AG
2021
Letter Agreement dated April 29, 2021 by and between CRISPR Therapeutics, Inc. and Pfizer Inc
CRISPR Therapeutics AG
Biotechnology
2021
Second Amendment to Lease dated April __, 2021, by and between CRISPR Therapeutics, Inc. and 33 NYA OWNER (DE) LLC, as successor in interest to CRP/KING 33 NY AVE. OWNER, L.L.C
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
DE
2021
Lease, dated May 5, 2020, by and between CRISPR Therapeutics, Inc. and CRP/KING 33 NY AVE. OWNER, L.L.C
Lease Agreements
CRISPR Therapeutics AG
2021
First Amendment to Lease dated December 2, 2020, by and between CRISPR Therapeutics, Inc. and CRP/KING 33 NY AVE. OWNER, L.L.C
Lease Agreements
CRISPR Therapeutics AG
2021
First Amendment to the Strategic Collaboration and License Agreement dated March 17, 2021, between CRISPR Therapeutics AG and Vertex Pharmaceuticals Incorporated
Collaboration Agreements
CRISPR Therapeutics AG
2021
Description of Capital Shares
CRISPR Therapeutics AG
2021
Lease, dated July 24, 2020, by and between the Registrant and 105 W First Street Owner, L.L.C
Lease Agreements
CRISPR Therapeutics AG
2020
Underwriting Agreement, dated as of June 30, 2020, among CRISPR Therapeutics AG and Goldman Sachs & Co. LLC, BofA Securities, Inc. and Jefferies LLC, as representatives of the...
Underwriting Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2020
Amendment No. 1 to Research Collaboration Agreement by and between CRISPR Therapeutics AG and ViaCyte, Inc., dated as of April 30, 2019
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2020
Assignment of Sublease and Sub-Sublease, dated December 13, 2019, between Casebia Therapeutics LLC and CRISPR Therapeutics, Inc
Lease Agreements
CRISPR Therapeutics AG
2020
Option Agreement, dated December 13, 2019, between CRISPR Therapeutics AG and Bayer HealthCare LLC
CRISPR Therapeutics AG
Biotechnology
NY
2020
Retirement Agreement, dated December 13, 2019, among Casebia Therapeutics Limited Liability Partnership, Bayer HealthCare LLC, CRISPR Therapeutics AG and CRISPR Therapeutics, Inc
Retirement Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2020
Joint Venture Termination Agreement, dated December 13, 2019, among Bayer Healthcare LLC (and certain affiliates of Bayer Healthcare LLC for purposes of Article II), CRISPR...
Joint Venture Agreements
CRISPR Therapeutics AG
2020
Amendment No. 2 to Research Collaboration Agreement by and between CRISPR Therapeutics AG and ViaCyte, Inc., dated as of October 21, 2019
Collaboration Agreements
CRISPR Therapeutics AG
2020
Description of Capital Shares
CRISPR Therapeutics AG
Biotechnology
2020
Termination Agreement, dated December 27, 2019, by and between CRISPR Therapeutics AG and Rodger Novak
Termination Agreements
CRISPR Therapeutics AG
Biotechnology
2019
Mandate Agreement, dated December 27, 2019, by and between CRISPR Therapeutics AG and Oriolus Consulting LLC
Consulting Agreements
CRISPR Therapeutics AG
2019
Underwriting Agreement, dated as of November 20, 2019, among CRISPR Therapeutics AG and Goldman Sachs & Co. LLC, Piper Jaffray & Co. and Jefferies LLC, as representatives of the...
Underwriting Agreements
CRISPR Therapeutics AG
2019
Open Market Sale AgreementSM, dated August 30, 2019, by and between CRISPR Therapeutics AG and Jefferies LLC
CRISPR Therapeutics AG
2019
Amendment No. 2 to the Strategic Collaboration, Option and License Agreement by and between, on the one hand, Vertex Pharmaceuticals Incorporated and Vertex Pharmaceuticals...
Collaboration Agreements
CRISPR Therapeutics AG
Biotechnology
2019
Strategic Collaboration and License Agreement dated June 6, 2019, between CRISPR Therapeutics AG and Vertex Pharmaceuticals Incorporated
Collaboration Agreements
CRISPR Therapeutics AG
2019
Underwriting Agreement, dated as of September 20, 2018, among CRISPR Therapeutics AG and Goldman Sachs & Co. LLC, Piper Jaffray & Co. and Barclays Capital Inc. as representatives...
Underwriting Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2018
Open Market Sale AgreementSM, dated August 31, 2018, by and between CRISPR Therapeutics AG and Jefferies LLC
CRISPR Therapeutics AG
Biotechnology
NY
2018
Employment Agreement, dated August 1, 2017, by and between CRISPR Therapeutics, Inc. and Tony Ho
Employment Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2018
Employment Agreement, dated November 13, 2017, by and between CRISPR Therapeutics, Inc. and Michael Tomsicek
Employment Agreements
CRISPR Therapeutics AG
2018
Senior Executive Cash Incentive Bonus Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
2018
Form of Restricted Stock Award Agreement for Non-Employee Directors under CRISPR Therapeutics AGs 2018 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Form of Restricted Stock Award Agreement under CRISPR Therapeutics AGs 2018 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
2018
Employment Agreement, dated May 31, 2017, by and between CRISPR Therapeutics, Inc. and James R. Kasinger
Employment Agreements
CRISPR Therapeutics AG
2018
CRISPR Therapeutics AG 2018 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Form of Incentive Stock Option Agreement under CRISPR Therapeutics AGs 2018 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
2018
Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under CRISPR Therapeutics AGs 2018 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
2018
Form of Restricted Stock Award Agreement for Company Employees under CRISPR Therapeutics AGs 2018 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2018
Underwriting Agreement, dated as of January 4, 2018, among CRISPR Therapeutics AG and Goldman Sachs & Co. LLC, Piper Jaffray & Co. and Barclays Capital Inc., as representatives of...
Underwriting Agreements
CRISPR Therapeutics AG
2018
Employment Agreement by and between CRISPR Therapeutics AG and Dr. Rodger Novak, dated as of December 20, 2017
Employment Agreements
CRISPR Therapeutics AG
Biotechnology
2017
Advisory Agreement by and between CRISPR Therapeutics AG and Dr. Anthony Coles, dated as of December 20, 2017
Advisory Agreements
CRISPR Therapeutics AG
2017
Amendment No. 1 to the Strategic Collaboration, Option and License Agreement by and between, on the one hand, Vertex Pharmaceuticals Incorporated and Vertex Pharmaceuticals...
Collaboration Agreements
CRISPR Therapeutics AG
2017
Joint Development and Commercialization Agreement by and between, on the one hand, Vertex Pharmaceuticals Incorporated and Vertex Pharmaceuticals (Europe) Limited, and on the...
Development Agreements
CRISPR Therapeutics AG
Biotechnology
DE
2017
Form of Restricted Stock Award Agreement for Company Employees under Registrants Amended and Restated 2016 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
2017
Form of Restricted Stock Award Agreement for Non-Employee Directors under CRISPR Therapeutics AGs Amended and Restated 2016 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2017
Form of Restricted Stock Award Agreement under CRISPR Therapeutics AGs Amended and Restated 2016 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
2017
Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under CRISPR Therapeutics AGs Amended and Restated 2016 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2017
Form of Non-Qualified Stock Option Agreement for Company Employees under Registrants Amended and Restated 2016 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
2017
Form of Incentive Stock Option Agreement under CRISPR Therapeutics AGs Amended and Restated 2016 Stock Option and Incentive Plan
Bonus & Incentive Agreements
CRISPR Therapeutics AG
2017
Second Amended and Restated Employment Agreement, dated October 2, 2017, by and between CRISPR Therapeutics, Inc. and Samarth Kulkarni
Employment Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2017
CRISPR THERAPEUTICS AG AMENDED AND RESTATED 2016 STOCK OPTION AND INCENTIVE PLAN
Bonus & Incentive Agreements
CRISPR Therapeutics AG
Biotechnology
2017
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
CRISPR Therapeutics AG
2017
[***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEENFILED WITH THE SECURITIES AND EXCHANGE...
Services Agreements
CRISPR Therapeutics AG
Biotechnology
CA
2016
CRISPR THERAPEUTICS AG Common Shares (nominal value CHF 0.03 per share) Underwriting Agreement
Underwriting Agreements
CRISPR Therapeutics AG
2016
REGISTRATION RIGHTS AGREEMENT made as of June 10, 2016 by andamong
Registration Rights Agreements
CRISPR Therapeutics AG
Biotechnology
2016
CONSENT TO SUBLEASE
Lease Agreements
CRISPR Therapeutics AG
2016
CRISPR THERAPEUTICS AG 2016 EMPLOYEE STOCK PURCHASE PLAN1
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2016
SUBSCRIPTION AGREEMENT
Subscription Agreements
CRISPR Therapeutics AG
2016
CRISPR THERAPEUTICS AG 2016 STOCK OPTION AND INCENTIVE PLAN1
Bonus & Incentive Agreements
CRISPR Therapeutics AG
2016
CRISPR THERAPEUTICS AG 2015 STOCK OPTION AND GRANT PLAN
Stock Agreements
CRISPR Therapeutics AG
Biotechnology
2016